Skip to Main Content

Author Details

Shanshan Pei
Zhejiang University Medical Center
2011
31
18
PMIDPaper TitleJournal TitlePublished Year
37358260A Novel Type of Monocytic Leukemia Stem Cell Revealed by the Clinical Use of Venetoclax-Based Therapy.Cancer Discov2023
37873284Targeting Acute Myeloid Leukemia Stem Cells Through Perturbation of Mitochondrial Calcium.bioRxiv2023
37393342Pharmacological GLUT3 salvage augments the efficacy of vitamin C-induced TET2 restoration in acute myeloid leukemia.Leukemia2023
37051756Higher-dose venetoclax with measurable residual disease-guided azacitidine discontinuation in newly diagnosed acute myeloid leukemia.Haematologica2023
37110126Therapy-Resistant Acute Myeloid Leukemia Stem Cells Are Resensitized to Venetoclax + Azacitidine by Targeting Fatty Acid Desaturases 1 and 2.Metabolites2023
34525179The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation.Blood2022
36194842Machine Learning-Based Exploratory Clinical Decision Support for Newly Diagnosed Patients With Acute Myeloid Leukemia Treated With 7 + 3 Type Chemotherapy or Venetoclax/Azacitidine.JCO Clin Cancer Inform2022
33028621The Hepatic Microenvironment Uniquely Protects Leukemia Cells through Induction of Growth and Survival Pathways Mediated by LIPG.Cancer Discov2021
34610123Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia.Blood Adv2021
32822582Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells.Cell Stem Cell2020
33884374Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells.Nat Cancer2020
31974170Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia.Cancer Discov2020
30753831Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells.Cancer Cell2019
31101624Cysteine depletion targets leukemia stem cells through inhibition of electron transport complex II.Blood2019
30943405The Hematopoietic Oxidase NOX2 Regulates Self-Renewal of Leukemic Stem Cells.Cell Rep2019
30852438Low ferroportin expression in AML is correlated with good risk cytogenetics, improved outcomes and increased sensitivity to chemotherapy.Leuk Res2019
30420752Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia.Nat Med2018
29969371Cladribine in combination with entinostat synergistically elicits anti-proliferative/anti-survival effects on multiple myeloma cells.Cell Cycle2018
29910151AMPK/FIS1-Mediated Mitophagy Is Required for Self-Renewal of Human AML Stem Cells.Cell Stem Cell2018
30423294Inhibition of Amino Acid Metabolism Selectively Targets Human Leukemia Stem Cells.Cancer Cell2018
28280079Targeted therapy for a subset of acute myeloid leukemias that lack expression of aldehyde dehydrogenase 1A1.Haematologica2017
27374788Leukemic Stem Cells Evade Chemotherapy by Metabolic Adaptation to an Adipose Tissue Niche.Cell Stem Cell2016
26589277SomVarIUS: somatic variant identification from unpaired tissue samples.Bioinformatics2016
27888238Rational design of a parthenolide-based drug regimen that selectively eradicates acute myelogenous leukemia stem cells.J Biol Chem2016
27573247Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells.J Biol Chem2016
24870236The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation.Nature2014
25483042Requirement for CRIF1 in RNA interference and Dicer-2 stability.RNA Biol2014
23333149BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.Cell Stem Cell2013
24089526Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells.J Biol Chem2013
23200537How close are we to targeting the leukemia stem cell?Best Pract Res Clin Haematol2012
21273084Melampomagnolide B: a new antileukemic sesquiterpene.Bioorg Med Chem2011
  • 1 - 31 of 31

Recommended Authors

Veronique Litalien
Walter and Eliza Hall Institute of Medical Research
Career Start Year 2016
Number of shared co-authors 0
Justin M Watts
University of Miami, Sylvester Comprehensive Cancer Center
Career Start Year 2014
Number of shared co-authors 2
Reinaldo Dal Bello
Universite Paris Cite, INSERM, CNRS
Career Start Year 2012
Number of shared co-authors 0
Alexandre Puissant
Universite de Paris, INSERM, CNRS
Career Start Year 2007
Number of shared co-authors 1
Courtney D DiNardo
UT MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 1
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 2
Thomas Cluzeau
Universite Nice Cote d'azur, CHU de Nice
Career Start Year 2005
Number of shared co-authors 0
Ronan Swords
Oregon Health and Science University
Career Start Year 2004
Number of shared co-authors 2
Tara L Lin
University of Kansas Medical Center
Career Start Year 2004
Number of shared co-authors 2
Anna M Eiring
Texas Tech University Health Sciences Center at El Paso
Career Start Year 2004
Number of shared co-authors 0
Jeffrey W Tyner
Oregon Health & Science University School of Medicine
Career Start Year 2002
Number of shared co-authors 8
Rose Hurren
Princess Margaret Cancer Centre
Career Start Year 1999
Number of shared co-authors 2
Elie Traer
Oregon Health & Science University
Career Start Year 1998
Number of shared co-authors 4
Ravindra Majeti
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 3
Guillermo Garcia-Manero
MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Farhad Ravandi
University of Texas M.D. Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Bruno C Medeiros
AbbVie Inc.
Career Start Year 1996
Number of shared co-authors 3
Brian J P Huntly
University of Cambridge
Career Start Year 1996
Number of shared co-authors 1
Timothy S Pardee
Comprehensive Cancer Center of Wake Forest Baptist Health, Medical Center Boulevard
Career Start Year 1995
Number of shared co-authors 0
Michael Heuser
Hannover Medical School
Career Start Year 1993
Number of shared co-authors 2
Gautam Borthakur
MD Anderson Cancer Center
Career Start Year 1992
Number of shared co-authors 2
Ravi Bhatia
University of Alabama at Birmingham
Career Start Year 1992
Number of shared co-authors 4
Peter Westervelt
Washington University School of Medicine
Career Start Year 1990
Number of shared co-authors 1
Daniel J DeAngelo
Dana-Farber Cancer Institute
Career Start Year 1989
Number of shared co-authors 2
Aaron D Schimmer
Princess Margaret Cancer Centre
Career Start Year 1989
Number of shared co-authors 3
Richard M Stone
Dana Farber Cancer Institute
Career Start Year 1986
Number of shared co-authors 3
Marcela Gronda
Princess Margaret Cancer Centre
Career Start Year 1985
Number of shared co-authors 2
Martin S Tallman
Memorial Sloan-Kettering Cancer Center
Career Start Year 1982
Number of shared co-authors 2
Hagop Kantarjian
The University of Texas MD Anderson Cancer Center
Career Start Year 1982
Number of shared co-authors 2
Steven M Kornblau
The University of Texas MD Anderson Cancer Center
Career Start Year 1980
Number of shared co-authors 2

Collaborators

Veronica Clavijo Jordan
Harvard Medical School
Co-authored papers 27
Brett M Stevens
University of Colorado School of Medicine
Co-authored papers 21
Mohammad Minhajuddin
University of Colorado School of Medicine
Co-authored papers 19
Daniel A Pollyea
University of Colorado Division of Hematology
Co-authored papers 19
Clayton A Smith
University of Colorado, Aurora CO.
Co-authored papers 14
Angelo D'Alessandro
University of Colorado Anschutz Medical Campus
Co-authored papers 13
Courtney L Jones
Princess Margaret Cancer Centre, University Health Network
Co-authored papers 11
Haobin Ye
Institute of Metabolism & Integrative Biology, Fudan University
Co-authored papers 10
Maria Amaya
University of Colorado School of Medicine
Co-authored papers 9
Amanda Winters
University of Colorado School of Medicine
Co-authored papers 9
Biniam Adane
The Broad Institute of MIT and Harvard
Co-authored papers 8
Rachel Culp-Hill
University of Colorado Anschutz Medical Campus
Co-authored papers 8
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Co-authored papers 7
Anna Krug
University of Colorado School of Medicine
Co-authored papers 7
Diana Abbott
Center for Innovative Design and Analysis, University of Colorado, Aurora CO.
Co-authored papers 6
Anagha Inguva
University of Colorado School of Medicine
Co-authored papers 6
Travis Nemkov
University of Colorado Anschutz Medical Campus
Co-authored papers 6
Maura Gasparetto
University of Colorado School of Medicine
Co-authored papers 6
Julie A Reisz
University of Colorado Anschutz Medical Campus
Co-authored papers 5
James DeGregori
University of Colorado Anschutz Medical Campus
Co-authored papers 4
Subhajyoti De
Co-authored papers 3
Kirk C Hansen
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Fabia Gamboni
University of Colorado Anschutz Medical Campus
Co-authored papers 2
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Co-authored papers 1
Jeremy N Rich
UPMC Hillman Cancer Center, University of Pittsburgh Medical Center
Co-authored papers 1
Sarah Gehrke
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Co-authored papers 1
Tonya Brunetti
Co-authored papers 1
Annika Gustafson
University of Colorado Denver
Co-authored papers 1
Stephen C Mack
St Jude Children's Research Hospital
Co-authored papers 1
Release 1.2